
Essex Bio-Technology Investor Relations Material
Latest events

H2 2024
26 Mar, 2025

H1 2024
25 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Essex Bio-Technology Limited
Access all reports
Essex Bio-Technology Limited is a biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic products. The company focuses on regenerative medicine and specializes in biopharmaceutical drugs for ophthalmology and wound care. Its product portfolio includes formulations derived from recombinant DNA technology and other biological sources. Essex Bio-Technology Limited conducts its operations through integrated facilities that support clinical research, production, and distribution. The company is headquartered in Hong Kong, China, and its shares are listed on the HKEX.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
1061
Country
🇭🇰 Hong Kong